Aptorum Group Limited announced on August 4, 2025, that it received formal written notification from The Nasdaq Stock Market, LLC, confirming that the company has regained compliance with Nasdaq’s minimum bid price requirement.
The company achieved compliance by maintaining a closing bid price of at least $1.00 for a minimum of 10 consecutive business days. This period occurred from July 16, 2025, to July 30, 2025, prior to the October 14, 2025, deadline.
This resolution means that the matter of non-compliance with Nasdaq Listing Rule 5550(a)(2) is now closed. Regaining compliance ensures Aptorum Group's continued listing on Nasdaq, which is vital for its operational stability and strategic initiatives, including the recently announced merger with DiamiR Biosciences.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.